Cart
sales@molnova.com
Etidocaine Hydrochloride
CAS No. 36637-19-1
Etidocaine Hydrochloride( Duranest | W-19053 | W 19053 | W19053 )
Catalog No. M27981 CAS No. 36637-19-1
Etidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 186 | In Stock |
|
| 10MG | 275 | In Stock |
|
| 25MG | 440 | In Stock |
|
| 50MG | 584 | In Stock |
|
| 100MG | 760 | In Stock |
|
| 200MG | 1004 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtidocaine Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
-
DescriptionEtidocaine Hydrochloride is a long-acting anesthetic and a blocker of the voltage-gated sodium channel.
-
In VitroIGL-EDC formulations can induce a significant increase in human fibroblasts survival. Cell Viability Assay Cell Line:Human fibroblasts cells Concentration:0, 4, 8, 16, 24 mM Incubation Time:4, 6 and 24 h Result:Showed that cell survival decreased in a (EDC) concentration with time-dependent manner.
-
In VivoEtidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit. Animal Model:Adult Swiss Webster male mice Dosage:0.0075% Administration:Etidocaine(spinal injection, 0.0075%, once)Result:Did not show postinjection neurologic deficit.
-
SynonymsDuranest | W-19053 | W 19053 | W19053
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorD2|5-HT2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number36637-19-1
-
Formula Weight313.89
-
Molecular FormulaC17H30ClN2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (199.76 mM)
-
SMILESCl.CCC[NH](CC)C(CC)C(=O)Nc1c(C)cccc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yamazaki S, et al. Comparison of prediction methods for in vivo clearance of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride, a dopamine D2 receptor antagonist, in humans. Drug Metab Dispos. 2004 Apr;32(4):398-404.
molnova catalog
related products
-
APETx2
Acid-sensing ion channel 3 (ASIC3) channel blocker (IC50 values are 63 and 175 nM for homomeric rat and human ASIC3 channels). Also inhibits NaV1.8 and NaV1.2 channels (IC50 values are 55 and 114 nM respectively). Demonstrates analgesic properties against acid-induced and inflammatory pain.
-
PF-04531083
PF-04531083 (PF 4531083) is a potent and selective, orally available sodium channel Nav1.8 blocker for treatment of pain.
-
R 56865
R 56865 is a weak potential-operated channel inhibitor that inhibits the late sodium current in human isolated cardiomyocytes.
